Department of Brain and Neurosciences, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
Laboratory of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113-0033, Japan.
Brain. 2023 Dec 1;146(12):4988-4999. doi: 10.1093/brain/awad272.
Pathological tau accumulates in the brain in tauopathies such as Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration, and forms amyloid-like filaments incorporating various post-translational modifications (PTMs). Cryo-electron microscopic (cryo-EM) studies have demonstrated that tau filaments extracted from tauopathy brains are characteristic of the disease and share a common fold(s) in the same disease group. Furthermore, the tau PTM profile changes during tau pathology formation and disease progression, and disease-specific PTMs are detected in and around the filament core. In addition, templated seeding has been suggested to trigger pathological tau amplification and spreading in vitro and in vivo, although the molecular mechanisms are not fully understood. Recently, we reported that the cryo-EM structures of tau protofilaments in SH-SY5Y cells seeded with patient-derived tau filaments show a core structure(s) resembling that of the original seeds. Here, we investigated PTMs of tau filaments accumulated in the seeded cells by liquid chromatography/tandem mass spectrometry and compared them with the PTMs of patient-derived tau filaments. Examination of insoluble tau extracted from SH-SY5Y cells showed that numerous phosphorylation, deamidation and oxidation sites detected in the fuzzy coat in the original seeds were well reproduced in SH-SY5Y cells. Moreover, templated tau filament formation preceded both truncation of the N-/C-terminals of tau and PTMs in and around the filament core, indicating these PTMs may predominantly be introduced after the degradation of the fuzzy coat.
病理性 tau 蛋白在神经退行性疾病中积累,如阿尔茨海默病、匹克氏病、进行性核上性麻痹和皮质基底节变性,形成类似于淀粉样的纤维,包含各种翻译后修饰(PTM)。低温电子显微镜(cryo-EM)研究表明,从神经退行性疾病大脑中提取的 tau 纤维具有疾病特征,并在同一疾病组中共享共同的折叠。此外,tau 蛋白的 PTM 谱在 tau 病理形成和疾病进展过程中发生变化,并且在纤维核心及其周围检测到疾病特异性的 PTM。此外,已经有人提出模板引发的种子会在体外和体内引发病理性 tau 扩增和传播,尽管分子机制尚未完全了解。最近,我们报道了在源自患者的 tau 纤维接种的 SH-SY5Y 细胞中,tau 原纤维的 cryo-EM 结构显示出类似于原始种子的核心结构。在这里,我们通过液相色谱/串联质谱法研究了接种细胞中积累的 tau 纤维的 PTM,并将其与源自患者的 tau 纤维的 PTM 进行了比较。对从 SH-SY5Y 细胞中提取的不溶性 tau 的检查表明,在原始种子的模糊外套中检测到的许多磷酸化、脱酰胺和氧化位点在 SH-SY5Y 细胞中得到了很好的重现。此外,模板 tau 纤维的形成先于 tau 的 N-和 C-末端的截断以及纤维核心及其周围的 PTM,表明这些 PTM 可能主要是在模糊外套降解后引入的。